Search results
Dry Brushing Is a Popular Body Treatment, But Does It Actually Do Anything?
Allure via Yahoo News· 6 days agoAs Dr. Grossman mentioned, dry brushing can make skin more sensitive, so skin that's already...
Shoppers Have Noticed ‘Significant Improvement’ in Their Skin Texture With This $13 SPF Face Cream
SheKnows· 2 days agoOne crucial aspect of improving skin texture is preventing new damage caused by harmful UV rays. Sun...
Chart Review Highlights Unique AD Features in Older Patients
Medscape· 2 days agoMore research is "needed to elucidate the unique features of elderly AD in pathophysiology and...
Q1 2024 STRATA Skin Sciences Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoForward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks ...
Healthy Living: Let's destigmatize talking about mental health
Asheville Citizen-Times via Yahoo News· 4 days agoIt helped to control my breathing and get me grounded. Once I graduated college, the attacks...
What Is "Iron Therapy"? A Potential New Approach To Tackling Asthma
Inverse· 3 days agoYou might also know that it’s an essential trace element that is a major component of hemoglobin, a...
These 2 No-Brainer Growth Stocks Are Breaking New Ground | The Motley Fool
The Motley Fool· 5 days agoEli Lilly (LLY -2.02%) and Regeneron Pharmaceuticals (REGN -1.05%) have historically been in the...
Iron fuels immune cells—and it could make asthma worse
Medical Xpress· 6 days agoA lesser known important function of iron is its involvement in generating energy for certain immune...
How Does Incyte Stock’s Decline During The 2022 Inflation Shock Compare With The 2008 Crash?
Forbes· 7 days agoINCY stock was trading at around $76 in early June 2022, just before the Fed started increasing...
Johnson & Johnson plans $850M Proteologix acquisition
NJBIZ· 1 day agoJohnson & Johnson plans to shell out $850 million to acquire Proteologix Inc. The privately held California biotech focuses on bispecific antibodies for immune-mediated diseases. A May 16 press ...